The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience.
about
Assistive technology for rheumatoid arthritisUsing N-of-1 trials to improve patient management and save costsManagement of Neuroacanthocytosis Syndromes"Me's me and you's you": Exploring patients' perspectives of single patient (n-of-1) trials in the UKEffect of increasing doses of beta agonists on spirometric parameters, exercise capacity, and quality of life in patients with chronic airflow limitationA comparison of four methods for the analysis of N-of-1 trialsEvaluating the Individualized Treatment of Traditional Chinese Medicine: A Pilot Study of N-of-1 Trials.N-of-1 trials of expensive biological therapies: a third way?Economic evaluation alongside n-of-1 trials: getting closer to the margin.A diagnostic and therapeutic N-of-1 randomized trial.Conducting research in individual patients: lessons learnt from two series of N-of-1 trialsImplementing EBLIP: if it works in Edmonton will it work in Newcastle?N of 1 trials and the optimal individualisation of drug treatments: a systematic review protocolPentoxifylline for ischemic pain in pseudoxanthoma elasticum.Removal of Diethylhexyl Phthalate from Hands by Handwashing: Evidence from Experimental N-of-1 and Crossover Designs.Selecting a change and evaluating its impact on the performance of a complex adaptive health care delivery system.Community-led trials: Intervention co-design in a cluster randomised controlled trial.Monitoring in chronic disease: a rational approach.Group analysis versus individual response: the inferential limits of randomized controlled trialsIndividual (N-of-1) trials can be combined to give population comparative treatment effect estimates: methodologic considerationsUse of the single subject design for practice based primary care researchToward a systematic approach to opioid rotation.From concepts, theory, and evidence of heterogeneity of treatment effects to methodological approaches: a primerReview article: Single subject trials as a research instrument in gastrointestinal pharmacology.Effect of tetrahydroaminoacridine on cognition, function and behaviour in Alzheimer's disease.To whom do the research findings apply?Reversing stroke in the 2010s: lessons from Desmoteplase In Acute ischemic Stroke-2 (DIAS-2).How can clinicians incorporate research advances into practice?Problems with using mechanisms to solve the problem of extrapolation.Determining whether a patient is feeling better: pitfalls from the science of human perception.Switching from NSAIDs to paracetamol: a series of n of 1 trials for individual patients with osteoarthritis.The genomics of micronutrient requirementsN-of-1 randomized trials for psychological and health behavior outcomes: a systematic review protocol.Somatic Cough Syndrome (Previously Referred to as Psychogenic Cough) and Tic Cough (Previously Referred to as Habit Cough) in Adults and Children: CHEST Guideline and Expert Panel ReportFeasibility and potential effectiveness of a non-pharmacological multidisciplinary care programme for persons with generalised osteoarthritis: a randomised, multiple-baseline single-case study.The effects of the dopamine agonist rotigotine on hemispatial neglect following stroke.Randomised study of n of 1 trials versus standard practice.n of 1 trials comparing a non-steroidal anti-inflammatory drug with paracetamol in osteoarthritis.Methodology guideline for clinical studies investigating traditional Chinese medicine and integrative medicine: executive summary.Efficacy of ultra-micronized palmitoylethanolamide (um-PEA) in geriatric patients with chronic pain: study protocol for a series of N-of-1 randomized trials.
P2860
Q24240705-318B4990-7EEE-4003-81F1-2A85DFDF82F7Q24594944-FBADE0E6-8F38-4C07-89F8-3D82E453B6F3Q26778623-7B068E79-8477-4C75-B36F-D16584B1163CQ28221205-A1DE4049-5FB2-4F2F-A74D-60734E04BA85Q28369237-11E511EC-85BA-4856-97C2-CF48A6ABBDFAQ28539492-82D15A12-C11E-4A7F-B183-D66441F00BE9Q30369425-26B0DD7B-1AE2-47AD-8A09-14D308B6C29DQ30483827-12ED05AC-3434-4F2E-992D-8F2B876E18FDQ31949941-C628311A-6687-4C90-818B-4AB62509D196Q33174545-4D8E8840-BD25-409A-AAA1-C1351E861752Q33258043-D9C012A1-6C2B-442B-832A-ABE45A7D1F9FQ33336795-36839A48-1A1D-4089-B560-3BF87802425EQ33595741-08399B4E-EA24-42DA-8CBA-0D8F658392ACQ33607765-4BB18F84-B02D-43A2-A418-B2CDA8836B71Q33673653-A5223AFD-CF7D-4EE2-8C83-2D33EE26757AQ33881101-340BED73-5A2D-4446-84D1-68802D823247Q33896254-D795BB91-9FCB-495F-B297-07FFB97B44E7Q33932916-3CE447A3-147D-41D4-9E42-3DF0935032D4Q34192035-9E3AA8E3-02E1-43C7-9F8F-E944B7E3A606Q34238602-9C7A7922-046E-458B-BAE7-068556124F87Q34313042-C5710EC8-6595-471B-9100-A6B2069C209CQ34394425-3FBEAED8-1630-4D62-9865-EABC37BD9ACAQ34509675-A1976F94-7729-48F5-8607-4FDD3688CC42Q34541690-7F16DD0B-2DBB-46B7-9233-07402F54FAA4Q34578939-70679C92-FA22-422F-AE65-3DBC0D811150Q34637623-1496D0D1-276B-4A7F-85DB-3497B5043DF3Q34683114-AEE06144-42AB-4A33-B007-D3B7D977DAB9Q34754147-CD3F2D6B-8692-4FF4-90D0-6A8E3862E23EQ34824317-E81C52AD-D5C9-422F-9071-20CDDE4D3E59Q35113148-7791FF5B-F64D-4430-92E8-AA8DB10D00C4Q35552282-D21E71FB-1CB0-4DC0-81B6-FA88373FAF72Q35614830-80A0AA83-838A-4917-938F-2009CAA040F6Q35665346-2B3AEB39-4E02-4EFC-9256-833012061C9AQ35825620-410C7624-8440-41B6-A3D9-EE90B958AE39Q36107959-18F7BA73-2321-4B74-9939-96D5C52B68A4Q36124394-A1E7DD13-7584-4E06-B6F1-57F583C00F19Q36598244-4EE2EC3A-7066-44B5-9323-2BA618AB3E29Q36888170-8B0B6554-8D1D-4D2D-87AF-28A7F885E76AQ36960891-68D4FE96-7458-42DA-BE90-D789AEA8D504Q37138714-334E8B84-39AB-4343-A757-FBAA7F17E627
P2860
The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience.
description
1990 nî lūn-bûn
@nan
1990 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience.
@ast
The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience.
@en
type
label
The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience.
@ast
The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience.
@en
prefLabel
The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience.
@ast
The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience.
@en
P2093
P1476
The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience.
@en
P2093
D Rosenbloom
G H Guyatt
J D Adachi
J L Keller
M T Newhouse
R Jaeschke
P304
P356
10.7326/0003-4819-112-4-293
P407
P577
1990-02-01T00:00:00Z